Founder, CMO & director Dr. Singh takes 12-month sabbatical; resigns from board

Vivos Therapeutics, Inc.

Sabbatical effective Sept 1, 2021 for 12 months; compensation and benefits unchanged.
Dr. Singh resigned from board of directors effective Sept 22, 2021.
Duties reduced to advising on clinical studies, device development, and conferences.
Board may reinstate or modify duties 30 days before sabbatical ends; extension possible.
Company believes sabbatical will not impact operations; ties to Stanford seen as growth opportunity.

item 1.01 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. G. Dave Singh

director

VVOS · Vivos Therapeutics, Inc.

Effective: 2021-09-22
Filed: September 27, 2021, 7:59 PM ET

he has resigned as a member of the Company’s board of directors (the “Board”), effective September 22, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. G. Dave Singh resigned as director at Vivos Therapeutics, Inc..

Action: resigned
Role: director

Exact text from the filing

he has resigned as a member of the Company’s board of directors (the “Board”), effective September 22, 2021.

View on SEC.gov

Vivos Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-21-023805

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.